168 related articles for article (PubMed ID: 38501199)
1. Drug-induced interstitial lung disease: a narrative review of a clinical conundrum.
Harrison M; Kavanagh G; Corte TJ; Troy LK
Expert Rev Respir Med; 2024; 18(1-2):23-39. PubMed ID: 38501199
[TBL] [Abstract][Full Text] [Related]
2. Interstitial lung disease induced by drugs and radiation.
Camus P; Fanton A; Bonniaud P; Camus C; Foucher P
Respiration; 2004; 71(4):301-26. PubMed ID: 15316202
[TBL] [Abstract][Full Text] [Related]
3. mTOR inhibitor-induced interstitial lung disease in cancer patients: Comprehensive review and a practical management algorithm.
Willemsen AE; Grutters JC; Gerritsen WR; van Erp NP; van Herpen CM; Tol J
Int J Cancer; 2016 May; 138(10):2312-21. PubMed ID: 26452336
[TBL] [Abstract][Full Text] [Related]
4. A Delphi consensus statement for the management of post-COVID interstitial lung disease.
Hadda V; Suri TM; Iyer H; Jain A; Mittal S; Madan K; Mohan A; Seith Bhalla A; Sindhwani G; Dutt N; Venkatnarayan K; Nath A; Dhooria S; Kumar R; Marwah V; Karmakar S; Chaudhry D; Ayub II; Dwivedi DP; Tiwari P; Koul P; Behera AK; Saxena P; Sengupta A; Mohapatra PR; Goyal A; Christopher DJ; Guleria R
Expert Rev Respir Med; 2022 Sep; 16(9):983-995. PubMed ID: 36154545
[TBL] [Abstract][Full Text] [Related]
5. Iatrogenic pulmonary lesions.
Roden AC; Camus P
Semin Diagn Pathol; 2018 Jul; 35(4):260-271. PubMed ID: 29631763
[TBL] [Abstract][Full Text] [Related]
6. Smoking-associated interstitial lung disease: update and review.
Dawod YT; Cook NE; Graham WB; Madhani-Lovely F; Thao C
Expert Rev Respir Med; 2020 Aug; 14(8):825-834. PubMed ID: 32379511
[TBL] [Abstract][Full Text] [Related]
7. Impact of interstitial lung disease associated with immune checkpoint inhibitors on prognosis in patients with non-small-cell lung cancer.
Yamagata A; Yokoyama T; Fukuda Y; Ishida T
Cancer Chemother Pharmacol; 2021 Feb; 87(2):251-258. PubMed ID: 33394102
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms and management of cough in interstitial lung disease.
Rasheed AZ; Metersky ML; Ghazal F
Expert Rev Respir Med; 2023 Dec; 17(12):1177-1190. PubMed ID: 38159067
[TBL] [Abstract][Full Text] [Related]
9. Association between baseline pulmonary status and interstitial lung disease in patients with non-small-cell lung cancer treated with erlotinib--a cohort study.
Johkoh T; Sakai F; Kusumoto M; Arakawa H; Harada R; Ueda M; Kudoh S; Fukuoka M
Clin Lung Cancer; 2014 Nov; 15(6):448-54. PubMed ID: 25043209
[TBL] [Abstract][Full Text] [Related]
10. Drug-Induced Interstitial Lung Diseases.
Ng N; Padilla ML; Camus P
Immunol Allergy Clin North Am; 2023 May; 43(2):341-357. PubMed ID: 37055092
[TBL] [Abstract][Full Text] [Related]
11. Rheumatoid arthritis related interstitial lung disease.
Manfredi A; Cassone G; Luppi F; Atienza-Mateo B; Cavazza A; Sverzellati N; González-Gay MA; Salvarani C; Sebastiani M
Expert Rev Clin Immunol; 2021 May; 17(5):485-497. PubMed ID: 33779447
[TBL] [Abstract][Full Text] [Related]
12. Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: a systematic literature review.
Roubille C; Haraoui B
Semin Arthritis Rheum; 2014 Apr; 43(5):613-26. PubMed ID: 24231065
[TBL] [Abstract][Full Text] [Related]
13. Estimates of epidemiology, mortality and disease burden associated with progressive fibrosing interstitial lung disease in France (the PROGRESS study).
Nasser M; Larrieu S; Boussel L; Si-Mohamed S; Bazin F; Marque S; Massol J; Thivolet-Bejui F; Chalabreysse L; Maucort-Boulch D; Hachulla E; Jouneau S; Le Lay K; Cottin V
Respir Res; 2021 May; 22(1):162. PubMed ID: 34030695
[TBL] [Abstract][Full Text] [Related]
14. Incidence of pneumonitis/interstitial lung disease induced by HER2-targeting therapy for HER2-positive metastatic breast cancer.
Hackshaw MD; Danysh HE; Singh J; Ritchey ME; Ladner A; Taitt C; Camidge DR; Iwata H; Powell CA
Breast Cancer Res Treat; 2020 Aug; 183(1):23-39. PubMed ID: 32591987
[TBL] [Abstract][Full Text] [Related]
15. Trastuzumab Deruxtecan-Induced Interstitial Lung Disease/Pneumonitis in ERBB2-Positive Advanced Solid Malignancies: A Systematic Review.
Abuhelwa Z; Alloghbi A; Alqahtani A; Nagasaka M
Drugs; 2022 Jun; 82(9):979-987. PubMed ID: 35759121
[TBL] [Abstract][Full Text] [Related]
16. Interstitial Lung Disease in Patients With Systemic Sclerosis: Toward Personalized-Medicine-Based Prediction and Drug Screening Models of Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD).
Khedoe P; Marges E; Hiemstra P; Ninaber M; Geelhoed M
Front Immunol; 2020; 11():1990. PubMed ID: 33013852
[TBL] [Abstract][Full Text] [Related]
17. Association of Preexisting Interstitial Lung Abnormalities With Immune Checkpoint Inhibitor-Induced Interstitial Lung Disease Among Patients With Nonlung Cancers.
Shimoji K; Masuda T; Yamaguchi K; Sakamoto S; Horimasu Y; Nakashima T; Miyamoto S; Iwamoto H; Fujitaka K; Hamada H; Takeno S; Hide M; Teishima J; Ohdan H; Hattori N
JAMA Netw Open; 2020 Nov; 3(11):e2022906. PubMed ID: 33180128
[TBL] [Abstract][Full Text] [Related]
18. Incidence, risk factors, and prognosis of acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis.
Xie M; Zhu C; Ye Y
BMC Pulm Med; 2023 Jul; 23(1):255. PubMed ID: 37434169
[TBL] [Abstract][Full Text] [Related]
19. Drug-induced interstitial lung disease.
Spagnolo P; Bonniaud P; Rossi G; Sverzellati N; Cottin V
Eur Respir J; 2022 Oct; 60(4):. PubMed ID: 35332071
[TBL] [Abstract][Full Text] [Related]
20. [Chinese expert consensus on multidisciplinary discussion of interstitial lung disease].
;
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Dec; 46(12):1176-1188. PubMed ID: 37989522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
